Cardioparin 2850IU Injection
By Cardioparin
Rx
0ml Injection in a Vial

Composition
Nadroparin(2850IU)

Manufacturer - Chandra Bhagat Pharma Pvt Ltd
501, The Bureau, R C MARG, Nr.Chembur Naka, Chembur East, Mumbai - 400071

Expires on or after
October, 2025

liver
Safety Advice for Cardioparin 2850IU Injection in relation to liver issues is limited. It is essential to consult with your doctor regarding the use of this injection if you have liver disease. Prior consultation is crucial to ensure the safety and efficacy of Cardioparin 2850IU Injection in individuals with liver conditions.

kidney
Caution is advised for patients with severe kidney disease when using Cardioparin 2850IU Injection. Dose adjustment may be required. Consult your doctor for guidance.

alcohol
Consult your doctor before consuming alcohol with Cardioparin 2850IU Injection as it is uncertain if it is safe.

driving
When using Cardioparin 2850IU Injection, it is uncertain if driving abilities are affected. Refrain from driving if you have symptoms impairing focus and reaction time.

pregnancy
Cardioparin 2850IU Injection may not be safe during pregnancy as animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. Please consult your doctor before using Cardioparin 2850IU Injection.

breastfeeding
Caution It is recommended to avoid using Cardioparin 2850IU Injection while breastfeeding as it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Low molecular weight heparin (LMWH) |
Therapeutic Class | BLOOD RELATED |
Action Class | Low molecular weight Heparin (LMWH) |
₹240.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025